MAPT and Alzheimer disease: We observed similar effects of PU-AD in 3xTg-AD mice, where similar to PS19 mice, epichaperome inhibition restored long-term memory in 3xTg-AD mice to levels in WT mice (Supplementary Fig. 7A–D) and significantly reduced pathologic human tau levels without affecting mouse tau species (Supplementary Fig. 7E).